Literature DB >> 16304048

alphaIIbbeta3 biogenesis is controlled by engagement of alphaIIb in the calnexin cycle via the N15-linked glycan.

W Beau Mitchell1, JiHong Li, Deborah L French, Barry S Coller.   

Abstract

Although much is known about alphaIIbbeta3 structure and function, relatively little is understood about its biogenesis. Thus, we studied the kinetics of pro-alphaIIb production and degradation, focusing on whether proteasomal degradation or the calnexin cycle participates in these processes. In pulse-chase analyses, the time to half-disappearance of pro-alphaIIb (t1/2) was the same in (1) HEK293 cells transfected with (a) alphaIIb plus beta3, (b) alphaIIb alone, (c) mutant V298FalphaIIb plus beta3, or (d) I374TalphaIIb plus beta3; and (2) murine wild-type and beta3-null megakaryocytes. Inhibition of the proteasome prolonged the t1/2 values in both HEK293 cells and murine megakaryocytes. Calnexin coprecipitated with alphaIIb from HEK293 cells transfected with alphaIIb alone, alphaIIb plus beta3, and V298FalphaIIb plus beta3. For proteins in the calnexin cycle, removal of the terminal mannose residue of the middle branch of the core N-linked glycan results in degradation. Inhibition of the enzyme that removes this mannose residue prevented pro-alphaIIb degradation in beta3-null murine megakaryocytes. alphaIIb contains a conserved glycosylation consensus sequence at N15, and an N15Q mutation prevented pro-alphaIIb maturation, complex formation, and degradation. Our findings suggest that pro-alphaIIb engages the calnexin cycle via the N15 glycan and that failure of pro-alphaIIb to complex normally with beta3 results in proteasomal degradation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304048      PMCID: PMC1895385          DOI: 10.1182/blood-2005-07-2990

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly.

Authors:  F Hochstenbach; V David; S Watkins; M B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Structure of the platelet membrane glycoprotein IIb. Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors.

Authors:  M Poncz; R Eisman; R Heidenreich; S M Silver; G Vilaire; S Surrey; E Schwartz; J S Bennett
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

Review 3.  Glanzmann's thrombasthenia: the spectrum of clinical disease.

Authors:  J N George; J P Caen; A T Nurden
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

4.  Processing and assembly of the integrin, glycoprotein IIb-IIIa, in HEL cells.

Authors:  J P Rosa; R P McEver
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

5.  Efficient surface expression of platelet GPIIb-IIIa requires both subunits.

Authors:  T E O'Toole; J C Loftus; E F Plow; A A Glass; J R Harper; M H Ginsberg
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

6.  Biosynthesis and assembly of platelet GPIIb-IIIa in human megakaryocytes: evidence that assembly between pro-GPIIb and GPIIIa is a prerequisite for expression of the complex on the cell surface.

Authors:  A Duperray; A Troesch; R Berthier; E Chagnon; P Frachet; G Uzan; G Marguerie
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

7.  Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.

Authors:  A D Elbein; J E Tropea; M Mitchell; G P Kaushal
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

8.  Effect of deletion of glycoprotein IIb exon 28 on the expression of the platelet glycoprotein IIb/IIIa complex.

Authors:  M A Kolodziej; G Vilaire; S Rifat; M Poncz; J S Bennett
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

9.  The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin.

Authors:  D N Hebert; J X Zhang; W Chen; B Foellmer; A Helenius
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

10.  Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes.

Authors:  A Duperray; R Berthier; E Chagnon; J J Ryckewaert; M Ginsberg; E Plow; G Marguerie
Journal:  J Cell Biol       Date:  1987-06       Impact factor: 10.539

View more
  14 in total

1.  Mapping early conformational changes in alphaIIb and beta3 during biogenesis reveals a potential mechanism for alphaIIbbeta3 adopting its bent conformation.

Authors:  W Beau Mitchell; Jihong Li; Marta Murcia; Nathalie Valentin; Peter J Newman; Barry S Coller
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

2.  Proteasome function is required for platelet production.

Authors:  Dallas S Shi; Matthew C P Smith; Robert A Campbell; Patrick W Zimmerman; Zechariah B Franks; Bjorn F Kraemer; Kellie R Machlus; Jing Ling; Patrick Kamba; Hansjörg Schwertz; Jesse W Rowley; Rodney R Miles; Zhi-Jian Liu; Martha Sola-Visner; Joseph E Italiano; Hilary Christensen; Walter H A Kahr; Dean Y Li; Andrew S Weyrich
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

3.  Asn54-linked glycan is critical for functional folding of intercellular adhesion molecule-5.

Authors:  Tomohiro Ohgomori; Tomohisa Nanao; Akinori Morita; Masahiko Ikekita
Journal:  Glycoconj J       Date:  2011-12-21       Impact factor: 2.916

4.  Platelets present antigen in the context of MHC class I.

Authors:  Lesley M Chapman; Angela A Aggrey; David J Field; Kalyan Srivastava; Sara Ture; Katsuyuki Yui; David J Topham; William M Baldwin; Craig N Morrell
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

5.  Platelets: essential components of the immune system.

Authors:  Ramadan A Ali; Leah M Wuescher; Randall G Worth
Journal:  Curr Trends Immunol       Date:  2015

Review 6.  Protein degradation systems in platelets.

Authors:  B F Kraemer; A S Weyrich; S Lindemann
Journal:  Thromb Haemost       Date:  2013-09-19       Impact factor: 5.249

Review 7.  Glanzmann thrombasthenia: state of the art and future directions.

Authors:  Alan T Nurden; Xavier Pillois; David A Wilcox
Journal:  Semin Thromb Hemost       Date:  2013-08-08       Impact factor: 4.180

8.  Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome.

Authors:  Nayia Nicolaou; Coert Margadant; Sietske H Kevelam; Marc R Lilien; Michiel J S Oosterveld; Maaike Kreft; Albertien M van Eerde; Rolph Pfundt; Paulien A Terhal; Bert van der Zwaag; Peter G J Nikkels; Norman Sachs; Roel Goldschmeding; Nine V A M Knoers; Kirsten Y Renkema; Arnoud Sonnenberg
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

9.  Electron microscopy shows that binding of monoclonal antibody PT25-2 primes integrin αIIbβ3 for ligand binding.

Authors:  Dragana Nešić; Martin Bush; Aleksandar Spasic; Jihong Li; Tetsuji Kamata; Makoto Handa; Marta Filizola; Thomas Walz; Barry S Coller
Journal:  Blood Adv       Date:  2021-04-13

Review 10.  Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.

Authors:  Natalie Mathews; Georges-Etienne Rivard; Arnaud Bonnefoy
Journal:  J Blood Med       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.